Company Name : Ankur Drugs Ltd
Address : C-306, Crystal Plaza, Andheri Link Road, Andheri (West), Mumbai – 400 053, India
Tel No: 91-022-40682300
Email : info@ankurdrugs.com, businessinquiries@ankurdrugs.com
Website http://www.ankurdrugs.com/
Company Profile
A public limited company listed at Bombay Stock Exchange and National Stock Exchange of India Limited achieved a turnover of INR10691.90 Million for year ended March 31, 2010. Ankur is extensively engaged in the manufacturing of pharmaceutical formulation since 1997, having multi location manufacturing units located at Daman and Baddi . The Company’s major expansion program with a view to cater to the international market has been validated for commissioning.
Ankur has to its credit several distinctions. It’s in the forefront of contract manufacturing with India’s leading and multinational pharmaceutical companies. Ankur’s first plant is situated at Daman, which is having dedicated block for General and Betalactum products in oral dosage form.
The Company has set-up two plants spread across “dimensions” at Himachal Pradesh in excise and pollution free zone, amongst lush green surroundings. The main object behind setting up two units was to cater Domestic and International Market.
Our more than 400 different formulations of various dosage forms i.e. Tablets, Capsules, Dry Syrups, Liquid Orals, Injectables, Oinments, etc. are currently manufactured in Ankur’s multi location manufacturing facilities. Company has already received WHO GMP Certification for both Units at Himachal Pradesh..
Hubli, May 20, 2024: In a significant move to support child nutrition through effective logistical contributions,…
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…